Compare Ginkgo Bioworks Holdings Inc (DNA) vs Hyperliquid Strategies Inc Common Stock (PURR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Hyperliquid Strategies Inc Common Stock — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Hyperliquid Strategies Inc Common Stock trades at $11.11 (market cap $2.24B). The key difference: Hyperliquid Strategies Inc Common Stock is far larger — about 2.9× Ginkgo Bioworks Holdings Inc's market cap, and Hyperliquid Strategies Inc Common Stock is more actively traded (14,135,020 versus 3,204,177). Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Hyperliquid Strategies Inc Common Stock for 1 Days on average.
| DNA | PURR | |
|---|---|---|
Market Cap | $763.64M | $2.24B |
Volume | 3,204,177 | 14,135,020 |
Sector | Health | Financials |
52-Week High | $15.83 | $14.09 |
52-Week Low | $5.48 | $3.10 |
Typical Hold Time | 7 Days | 1 Days |
Enterprise Value | $865.59M | $2.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →
